Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13757
Title: Glaucarubinone combined with gemcitabine improves pancreatic cancer survival in an immunocompetent orthotopic murine model
Austin Authors: Yeo, Dannel;Huynh, Nhi;Beutler, John A;Baldwin, Graham S;He, Hong ;Nikfarjam, Mehrdad 
Affiliation: Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Molecular Targets Laboratory, National Cancer Institute, Frederick, MD, USA
Issue Date: Dec-2016
Date: 2016-03-30
Publication information: Journal of Investigative Surgery 2016; 29(6): 366-372
Abstract: BACKGROUND: Pancreatic cancer continues to have a poor survival rate with an urgent need for improved treatments. Glaucarubinone, a natural product first isolated from the seeds of the tree Simarouba glauca, has recently been recognized as having anti-cancer properties that may be particularly applicable to pancreatic cancer. METHODS: The effect of glaucarubinone on the growth and migration of murine pancreatic cancer cells was assessed by 3H-thymidine incorporation assay. The survival impact of glaucarubinone alone and in combination with gemcitabine chemotherapy was assessed using an immunocompetent orthotopic murine model of pancreatic cancer. RESULTS: Glaucarubinone inhibited the growth of the murine pancreatic cancer cell lines LM-P and PAN02. Treatment with either glaucarubinone or gemcitabine reduced proliferation in vitro and the combination was synergistic. The combination treatment improved survival two-fold compared to gemcitabine treatment alone (p = 0.046) in PAN02 cells. CONCLUSIONS: The synergistic inhibition by glaucarubinone and gemcitabine observed in vitro and the improved survival in vivo suggest that glaucarubinone may be a useful adjunct to current chemotherapy regimens
URI: https://ahro.austin.org.au/austinjspui/handle/1/13757
ORCID: 0000-0002-0944-8747
0000-0003-4866-276X
Journal: Journal of Investigative Surgery
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27027695
Type: Journal Article
Subjects: Gemcitabine
Glaucarubinone
Prostatic Neoplasms
Appears in Collections:Journal articles

Show full item record

Page view(s)

16
checked on May 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.